Neurocrine Biosciences to Present at the 25th Annual SG Cowen & Company Healthcare Conference
Live Webcast on Wednesday, March 16, 2005
SAN DIEGO, March 14 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc., (Nasdaq: NBIX) a biopharmaceutical company focused on neurological and endocrine diseases and disorders announced today that Gary Lyons, President and CEO will present at the 25th Annual SG Cowen Healthcare Conference at the Boston Marriott Copley Place Hotel, Wednesday afternoon, March 16, 2005.
The initial presentation will take place at 2:20PM Eastern Standard Time (EST) / 11:20AM Pacific Standard Time (PST) and will include an overview of the Company as well as an update on the Company's broad development pipeline and research programs. This presentation will be webcast and can be accessed on the Company's website at http://www.neurocrine.com.
Immediately following the initial presentation, a second session will take place at 3:10PM EST and will provide members of the financial community and other interested investors an opportunity for an interactive question and answer period.
A replay of the webcast will be available approximately one hour after the presentation concludes and will be archived until Wednesday, March 30, 2005. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Jones or Elizabeth Foster.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com
SOURCE Neurocrine Biosciences, Inc.
03/14/2005
CONTACT: Investors, Claudia Jones, or Elizabeth Foster,
both of
Neurocrine Biosciences,
1-858-617-7600
Web site: http://www.neurocrine.com
(NBIX)